Based on the results, Novo Nordisk, the Danish drugmaker behind Ozempic, said it was filing for expanded indications for Ozempic in the U.S
Remember, your journey is about more than just a number on the scaleits about feeling your best and living a healthier, more balanced life
Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea
It's worth reading further before you decide - the details on how compounding status, approval gatekeeping, and refund terms actually work in practice matter a lot for this category
Most participants who experience GI symptoms during the first 20 weeks report minimal or no symptoms by month 12
While these drugs are very effective, working by making people feel full quickly after eating and slowing digestion, they come with a serious health risk - stomach paralysis
